Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 in D3 Deficient COPD Patients
NCT03781895Phase 1Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Mar 2017
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of vitamin d in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Forced Vital Capacity at 90 days, Forced Expiratory Volume in 1 Second at 90 days and 10 more. Started Mar 2017; status: completed.
02
Drugs
vitamin d
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03781895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781895.